These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30106153)

  • 21. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
    Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
    Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.
    Sato F; Kawamura H; Wu Y; Sato H; Jin D; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Kato Y; Kijima H
    Int J Mol Med; 2012 Sep; 30(3):495-501. PubMed ID: 22735690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP.
    Noshiro M; Kawamoto T; Furukawa M; Fujimoto K; Yoshida Y; Sasabe E; Tsutsumi S; Hamada T; Honma S; Honma K; Kato Y
    Genes Cells; 2004 Apr; 9(4):317-29. PubMed ID: 15066123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of basic helix-loop-helix transcription factors Dec1 and Dec2 by RORα and their roles in adipogenesis.
    Ozaki N; Noshiro M; Kawamoto T; Nakashima A; Honda K; Fukuzaki-Dohi U; Honma S; Fujimoto K; Tanimoto K; Tanne K; Kato Y
    Genes Cells; 2012 Feb; 17(2):109-21. PubMed ID: 22244086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific disruption of rhythmic expression of Dec1 and Dec2 in clock mutant mice.
    Noshiro M; Furukawa M; Honma S; Kawamoto T; Hamada T; Honma K; Kato Y
    J Biol Rhythms; 2005 Oct; 20(5):404-18. PubMed ID: 16267380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells.
    Ratz L; Laible M; Kacprzyk LA; Wittig-Blaich SM; Tolstov Y; Duensing S; Altevogt P; Klauck SM; Sültmann H
    Oncotarget; 2017 Apr; 8(15):25115-25130. PubMed ID: 28445989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis.
    Sato F; Bhawal UK; Sugiyama N; Osaki S; Oikawa K; Muragaki Y
    Clocks Sleep; 2020 Mar; 2(1):26-38. PubMed ID: 33089188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant dissociation of expression patterns of the basic helix-loop-helix transcription factors Dec1 and Dec2 in rat kidney.
    Wu T; Ni Y; Zhuge F; Sun L; Xu B; Kato H; Fu Z
    J Exp Biol; 2011 Apr; 214(Pt 8):1257-63. PubMed ID: 21430201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.
    Yunokawa M; Tanimoto K; Nakamura H; Nagai N; Kudo Y; Kawamoto T; Kato Y; Hiyama E; Hiyama K; Nishiyama M
    Oncol Rep; 2007 Apr; 17(4):871-8. PubMed ID: 17342330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter.
    Li Y; Xie M; Song X; Gragen S; Sachdeva K; Wan Y; Yan B
    J Biol Chem; 2003 May; 278(19):16899-907. PubMed ID: 12624110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1.
    Gallo C; Fragliasso V; Donati B; Torricelli F; Tameni A; Piana S; Ciarrocchi A
    Cell Death Dis; 2018 Aug; 9(9):871. PubMed ID: 30158530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells.
    Osorio LA; Farfán NM; Castellón EA; Contreras HR
    Mol Med Rep; 2016 Jan; 13(1):778-86. PubMed ID: 26648419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.
    Ehata S; Hanyu A; Hayashi M; Aburatani H; Kato Y; Fujime M; Saitoh M; Miyazawa K; Imamura T; Miyazono K
    Cancer Res; 2007 Oct; 67(20):9694-703. PubMed ID: 17942899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAL-1/4.1B contributes to epithelial-mesenchymal transition via regulation of transforming growth factor-β in lung cancer cell lines.
    Yu F; Yang H; Zhang Z; Wang Z; Xiong J
    Mol Med Rep; 2015 Oct; 12(4):6072-8. PubMed ID: 26300315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.